Qianjin Pharmaceutical Co., Ltd. in jiangduan: promote the strategy to take root with "Second Entrepreneurship"

[interview with people on chinapharma.com] as an old pharmaceutical enterprise established in 1966, Qianjin pharmaceutical industry has been transformed into a joint-stock company in 1993 and listed on the Shanghai Stock Exchange in 2004 With the leverage of capital, the main business of the company keeps growing In 2011, after jiangduan pre connected Qianjin pharmaceutical, it sounded the clarion call of "second business, passion investment" of Qianjin pharmaceutical (Jiang Duan, chairman of Qianjin pharmaceutical) "strategy opens the future We put forward the slogan of "secondary entrepreneurship", which is to adjust our thinking, formulate operational policies from the perspective of operation and management, promote the strategy to take root, and thus lead the development of enterprises " On January 17, Jiang Duan, chairman of Qianjin pharmaceutical, revealed in an exclusive interview with reporters in advance The newly disclosed pre increase announcement on January 10 also presents a "great gift" to the 50th anniversary of the establishment of Qianjin Pharmaceutical Group: the company expects that the net profit attributable to the shareholders of the listed company in 2016 will increase by 50% - 70% year on year An analyst who has been tracking Qianjin pharmaceutical industry for a long time in Hunan pointed out that "the explosive growth of Qianjin pharmaceutical industry's performance is inseparable from the strategic layout of" secondary entrepreneurship "launched by the company, in which the company has made very clear provisions on the medium-term goal, the development path of endogenous growth + extension development, and the direction of resource investment." At present, Qianjin pharmaceutical industry has initially established the whole pharmaceutical industry chain business structure including pharmaceutical manufacturing, pharmaceutical circulation and traditional Chinese medicine planting As the foothold of "secondary entrepreneurship", Qianjin pharmaceutical has determined the development strategy of "jumping out of Gynecology, being a series of women's health; jumping out of the industry, being a series of Chinese medicine derivatives", taking gynecology Chinese medicine as the core, and gradually extending to the field of women's health industry Jiang Duan said in an interview with reporters in advance: "at the beginning of the" second start-up ", we clearly required that we should be performance-oriented, talk about heroes based on performance, adhere to the" profit oriented "assessment mechanism, abandon the sales based model, encourage more to do, and change the phenomenon of balancing and eating the pot." According to the overall strategy of Qianjin pharmaceutical's "Second Entrepreneurship", 2016 is the first year of the 13th five year plan The company has carefully analyzed the industry situation and change trend, and made a reasonable five-year plan based on the principle of timely following the trend, acting according to the ability, developing the strengths and avoiding the weaknesses: determining the medium-term goal, taking profit, scale, assets and employee income as the main indicators; Determine the development path, clarify the priority of endogenous and extensional growth; improve resource investment direction, select promising and promising projects for investment; do a good job in goal decomposition, and implement tasks to all subsidiaries and relevant departments; formulate implementation steps, and achieve planning step by step according to time nodes In this regard, Shen wanhongyuan analyzed in the Research Report "layout of female health products and start Qianjin's second business", pointing out that Qianjin pharmaceutical has formulated the plan of integrating internal and external resources and improving its own industrial chain construction The company is expected to achieve the extension development, expand the medical service or medical technology field, improve the industrial chain and enhance the overall competitiveness with the help of capital market forces.